Adaptin Bio, Inc. (APTN) Operating cash flow 2023–2025
Adaptin Bio, Inc. (APTN) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$4.8MFY2025 · since FY2023: -$81,035 → -$4.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$4.8M | -635.9% |
| FY2024 | -$649,283 | -701.2% |
| FY2023 | -$81,035 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More APTN financial trends
APTN RevenueAPTN Net incomeAPTN Net marginAPTN Gross profitAPTN Gross marginAPTN Operating incomeAPTN Operating marginAPTN Free cash flowAPTN Capital expendituresAPTN Return on equityAPTN Stock buybacksAPTN Dividends paidAPTN Total assetsAPTN Total liabilitiesAPTN Shareholders’ equityAPTN overview →